
Soleno Therapeutics Inc
NASDAQ:SLNO

Intrinsic Value
The intrinsic value of one
SLNO
stock under the Base Case scenario is
113.36
USD.
Compared to the current market price of 76.7 USD,
Soleno Therapeutics Inc
is
Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Soleno Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Soleno Therapeutics Inc
Balance Sheet Decomposition
Soleno Therapeutics Inc
Current Assets | 293.9m |
Cash & Short-Term Investments | 291.4m |
Other Current Assets | 2.5m |
Non-Current Assets | 37.1m |
Long-Term Investments | 27.2m |
PP&E | 3m |
Intangibles | 6.8m |
Other Non-Current Assets | 83k |
Free Cash Flow Analysis
Soleno Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Soleno Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-187.7m
USD
|
Operating Income
|
-187.7m
USD
|
Other Expenses
|
11.8m
USD
|
Net Income
|
-175.9m
USD
|
SLNO Profitability Score
Profitability Due Diligence
Soleno Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Score
Soleno Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
SLNO Solvency Score
Solvency Due Diligence
Soleno Therapeutics Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Score
Soleno Therapeutics Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SLNO Price Targets Summary
Soleno Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SLNO
is 107.67 USD
with a low forecast of 81.81 USD and a high forecast of 152.25 USD.
Dividends
Current shareholder yield for SLNO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SLNO
stock under the Base Case scenario is
113.36
USD.
Compared to the current market price of 76.7 USD,
Soleno Therapeutics Inc
is
Undervalued by 32%.